Healthcare / Medical Care FacilitiesTokyo
$989.00
+12.00 (+1.23%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 24% · confianza 25%
FCF escenarios
weak_data · normalized FCF $392.7M · quality 62.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
45/100
C
Piotroski
8/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$7.1B
P/E
14.5x
↓EV/EBITDA
7.2x
↓ROE
30.3%
↑Gross Margin
24.1%
↓Debt/Equity
1.12
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+20.0%
FCF CAGR
+19.7%
FCF margin
3.9%
FCF / Net income
0.55x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $9.98B · net income $719.0M · FCF $392.7M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $9.98B | $9.98B | $8.29B | $6.66B | $5.78B |
| Net Income | $719.0M | $719.0M | $441.0M | $382.9M | $328.5M |
| EBITDA | $1.29B | $1.29B | $854.4M | $627.3M | $568.7M |
| EPS | 97.92 | 97.92 | 59.26 | 50.82 | 43.32 |
| Gross Margin | 24.1% | 24.1% | 22.7% | 23.5% | 21.4% |
| Operating Margin | 10.5% | 10.5% | 8.6% | 8.0% | 9.0% |
| Net Margin | 7.2% | 7.2% | 5.3% | 5.8% | 5.7% |
| Balance Sheet | |||||
| Debt/Equity | 1.12 | 1.12 | 1.70 | 0.17 | 0.31 |
| Current Ratio | 1.48 | 1.48 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $392.7M | $392.7M | $473.2M | $102.6M | $228.9M |
| Returns | |||||
| ROE | 30.3% | 30.3% | 26.8% | 25.8% | 30.6% |
| Valuation | |||||
| P/E | 14.46 | 14.46 | 31.78 | 46.28 | 85.87 |
| EV/EBITDA | 7.23 | 7.23 | 18.87 | 27.75 | 48.91 |
| P/B | 3.06 | 3.06 | 8.53 | 11.95 | 26.30 |
| Growth & Yield | |||||
| Revenue Growth | 20.5% | 20.5% | 24.5% | 15.1% | — |
| EPS Growth | 65.2% | 65.2% | 16.6% | 17.3% | — |
| Dividend Yield | 4.1% | 4.1% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
-3.6%
EPS terminal req.
$87.76
Spread vs growth
68.8%
5Y implied EPS CAGR
1.6%
EPS terminal req.
$106.19
Spread vs growth
63.6%
10Y implied EPS CAGR
5.7%
EPS terminal req.
$171.01
Spread vs growth
59.5%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-30.2%
Start / end P/E
25.4x → 10.1x
EPS bridge
59.26 → 97.92
Residual
-39.3%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.